# COVID-19 RELATED STUDY INVOLVING DOGS

> **NIH NIH N01** · IIT RESEARCH INSTITUTE · 2020 · $597,893

## Abstract

Human recombinant ACE2 will be administered to dogs as an aerosol to assess potential toxicities.  Results will be used to support an Investigational New Drug Application with the FDA for a clinical trial addressing patients with COVID-19 infection.

## Key facts

- **NIH application ID:** 10269151
- **Project number:** 75N91019D00013-0-759102000002-1
- **Recipient organization:** IIT RESEARCH INSTITUTE
- **Principal Investigator:** DAVID MCCORMICK
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $597,893
- **Award type:** —
- **Project period:** 2020-09-16 → 2021-03-15

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10269151

## Citation

> US National Institutes of Health, RePORTER application 10269151, COVID-19 RELATED STUDY INVOLVING DOGS (75N91019D00013-0-759102000002-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10269151. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*